AstraZeneca warns of shifting UK vaccine production to US, FT reports

AstraZeneca (AZN.L) has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock with the new Labour government over plans to cut state aid, the Financial Times reported, opens new tab on Thursday.